Abstract

Background: Mucous membrane pemphigoid (MMP) or cicatricial pemphigoid is an autoimmune disease associated with high morbidity. It presents as erosive mucosal lesions with scarring for which different treatments are used, depending on the degree of involvement. It may cause ocular complications requiring interdisciplinary management together with ophthalmology specialists because patients may need cataract surgery and corneal transplant in the event of perforation, or even a keratoprosthesis as the only option for visual rehabilitation. Case Presentation: Clinical case of the dermatology service of University Hospital La Samaritana in Bogota, Colombia. The patient presented with multiple illnesses and a longstanding history of the disease with no improvement despite multiple approaches to management. In view of disease activity after several treatments and because of the need for surgery, annual rituximab administration was instituted in an attempt at controlling the disease and avoiding reactivations. Conclusion: MMP is a disease associated with high morbidity. Diagnosis is usually delayed because onset of the disease is not evident at first and because of similarity with other diseases, resulting in the use of inadequate treatments in the absence of high quality evidence about potential interventions. In some cases, treatment for life is required in order to prevent progression.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.